Association of the G-protein β3 subunit gene polymorphism with the incidence of cardiovascular disease independent of hypertension: The Funagata study

Journal of Human Hypertension

Volumn 27, Issue 10, 2013, Pages 612-616

  Daimon, M ^a   Sato, H ^a,b   Kaino, W ^a   Tada, K ^a   Takase, K ^a   Karasawa, S ^a   Wada, K ^a   Kameda, W ^a   Susa, S ^a   Oizumi, T ^a   Kayama, T ^a   Muramatsu, M ^b,c   Kato, T ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b HuBit Genomix Research Institute   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Funagata study; G protein 3 subunit; Genetic variation; Hypertension; Population based study

Indexed keywords

ALCOHOL; CYSTEINE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA 3 SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPANESE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYMORPHISM, GENETIC; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884281217     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.28     Document Type: Article

References (35)

1. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003; 24: 765-781.
2. Farfel Z, Bourne HR, Iiri T. The expanding spectrum of G protein diseases. N Engl J Med 1999; 340: 1012-1020.
3. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18: 45-48.
4. Rosskopf D, Busch S, Manthey I, Siffert W. G protein beta gene: structure, promoter, and additional polymorphisms. Hypertension 2000; 36: 33-41.
5. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N et al. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 1995; 96: 759-766.
6. Virchow S, Ansorge N, Rübben H, Siffert G, Siffert W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele. FEBS Lett 1998; 436: 155-158.
7. Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens 2007; 25: 487-500.
8. Andersen G, Overgaard J, Albrechtsen A, Glümer C, Borch-Johnsen K, Jørgensen T et al. Studies of the association of the GNB3 825C4T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 2006; 49: 75-82.
9. Danoviz ME, Pereira AC, Mill JG, Krieger JE. Hypertension, obesity and GNB 3 gene variants. Clin Exp Pharmacol Physiol 2006; 33: 248-252.
10. Hayakawa T, Takamura T, Abe T, Kaneko S. Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese. Metabolism 2007; 56: 44-48.
11. Rosskopf D, Frey U, Eckhardt S, Schmidt S, Ritz E, Hofmann S et al. Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes. Eur J Med Res 2000; 5: 484-490.
12. Kiani JG, Saeed M, Parvez SH, Frossard PM. Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes. Neuro Endocrinol Lett 2005; 26: 87-88.
13. Ishikawa K, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K et al. Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am J Hypertens 2000; 13: 140-145.
14. Holmen OL, Romundstad S, Melien O. Association between the G protein b3 subunit C825T polymorphism and the occurrence of cardiovascular disease in hypertensives: the Nord-Trøndelag Health Study (HUNT). Am J Hypertens 2010; 23: 1121-1127.
15. Casiglia E, Tikhonoff V, Boschetti G, Bascelli A, Saugo M, Guglielmi G et al. The C825T GNB3 polymorphism, independent of blood pressure, predicts cerebrovascular risk at a population level. Am J Hypertens 2012; 25: 451-457.
16. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003; 26: 2015-2020.
17. Oizumi T, Daimon M, Jimbu Y, Wada K, Kameda W, Susa S et al. Impaired glucose tolerance is a risk factor for stroke in a Japanese sample - the Funagata study. Metabolism 2008; 57: 333-338.
18. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2508-2509.
19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 1998; 15: 539-553.
20. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated Report of a WHO Consultation. World Health Organization: Geneva, Switzerland, 2011.
21. Daimon M, Sato H, Sasaki S, Toriyama S, Emi M, Muramatsu M et al. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM. Biochem Biophys Res Commun 2008; 374: 576-580.
22. Yamamoto M, Abe M, Jin JJ, Wu Z, Tabara Y, Mogi M et al. Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese. Biochem Biophys Res Commun 2004; 316: 744-748.
23. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
24. Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 2006; 29: 26-31.
25. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-2354.
26. Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N et al. The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study. Hypertens Res 2005; 28: 879-887.
27. Nakamura Y, Ueshima H, Okamura T, Kadowaki T, Hayakawa T, Kita Y et al. Association between fish consumption and all-cause and cause-specific mortality in Japan: NIPPON DATA80, 1980-99. Am J Med 2005; 118: 239-245.
28. Rosskopf D, Manthey I, Habich C, Kielbik M, Eisenhardt A, Nikula C et al. Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J 2003; 371: 223-232.
29. Moor AN, Gan XT, Karmazyn M, Fliegel ML. Activation of Na+/H+ exchangerdirected protein kinases in the ischemic and ischemic-reperfused rat myocardium. J Biol Chem 2001; 276: 16113-16122.
30. Siffert W, Dü sing R. Sodium-proton exchange and primary hypertension. An update. Hypertension 1995; 26: 649-655.
31. Kedzierska K, Ciechanowski K, Safranow K, Bober J, Go"embiewska E, Kwiatkowska E et al. GNB3 C825T and ACE I/D polymorphisms on the sodium-proton exchanger and the prevalence of essential hypertension in males. Arch Med Res 2006; 37: 150-157.
32. Kuro-o M, Hanaoka K, Hiroi Y, Noguchi T, Fujimori Y, Takewaki S et al. Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ Res 1995; 76: 148-153.
33. Gö bel BO, Hoffmann G, Ruppert M, Stumpe KO, Vetter H, Siffert W et al. The lymphocyte Na+/H+ antiport: activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest 1994; 24: 529-539.
34. Yamagishi K, Tanigawa T, Cui R, Tabata M, Ikeda A, Yao M et al. G-protein beta-3 subunit C825T polymorphism, sodium and arterial blood pressure: a community-based study of Japanese men and women. Ann Hum Genet 2006; 70: 759-766.
35. Ministry of Health, Labour and Welfare of Japan. Summary Report, National Health and Nutritional Survey. Ministry of Health, Labour and Welfare of Japan: Tokyo, Japan, 2010, pp 36.